LONE TREE, Colo.--(BUSINESS WIRE)--Zynex, Inc. (OTCBB: ZYXI), a provider and developer of non-invasive medical devices for electrotherapy, stroke rehabilitation, neurological diagnosis and cardiac monitoring, announced that it has signed a private labeling and distribution agreement with ActivaTek, Inc. to sell and distribute a line of Iontophoresis products.
Zynex will begin selling the Iontophoresis products immediately through its US sales force in its Zynex Medical subsidiary. The products are typically sold and invoiced directly to physical therapy clinics.
Iontophoresis is a non-invasive method of propelling high concentrations of a medication transdermally by use of a small electrical charge (an injection without a needle). This method of drug delivery is commonly used to treat site-specific inflammatory and other musculoskeletal conditions and is typically administered in a series of treatments by a healthcare provider within the clinic. The product line consists of both a self-contained patch, similar to a large band aid, as well as the more traditional clinical dose controller to drive the current through the disposable delivery electrodes. The Iontophoresis market is well established, has existed over several decades and primarily allows clinics to get paid by health insurance as they treat their patients.
Zynex's CEO, Thomas Sandgaard, commented, "We are very excited about the addition of Iontophoresis devices to our existing product line. We believe the Iontophoresis products will not only provide opportunities for additional sales, but will also assist us in further penetrating our electrotherapy market. The Iontophoresis devices will be marketed and sold directly to our already existing base of customers within the pain and rehabilitation market."
ActivaTek CEO, Jamal Yanaki, stated, "We are excited to share our most advanced and flexible Iontophoresis technologies with Zynex."
About ActivaTek, Inc.
ActivaTek, Inc. is an innovative Iontophoretic Drug Delivery Company based in Salt Lake City, Utah.
For additional information please visit: http://www.activatekinc.com.
Zynex, Inc. (founded in 1996) operates under three primary business segments; Zynex Medical, Zynex NeuroDiagnostics and Zynex Monitoring Solutions. Zynex Medical engineers, manufactures, markets and sells its own design of electrotherapy medical devices for standard digital electrotherapy, used for pain relief, pain management and stroke and spinal cord injury rehabilitation. Zynex Medicals product lines are fully developed, FDA-cleared, commercially sold, and have been developed to uphold the Company's mission of improving the quality of life for patients suffering from impaired mobility due to stroke, spinal cord injury, or debilitating and chronic pain. Zynex NeuroDiagnostics, currently in the development stage, has been established to market EMG, EEG, sleep pattern, auditory and nerve conductivity neurological diagnosis devices through product development or acquisitions. Zynex Monitoring Solutions, currently in the development stage, has been established to develop and market medical devices for non-invasive cardiac monitoring.
For additional information please visit: http://www.ir-site.com/zynex/default.asp.